Silexion Therapeutics Raises $1.3M in Share Sale
Ticker: SLXNW · Form: 8-K · Filed: Jun 3, 2025 · CIK: 2022416
| Field | Detail |
|---|---|
| Company | Silexion Therapeutics Corp (SLXNW) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: capital-raise, share-sale, financing
Related Tickers: SLXN
TL;DR
Silexion Therapeutics is selling shares at $1.15 each, raising $1.3M by June 5th.
AI Summary
Silexion Therapeutics Corp. announced on June 3, 2025, that it has entered into a securities purchase agreement. The agreement involves the sale of 1,150,000 ordinary shares at a price of $1.15 per share, for a total gross proceeds of approximately $1,322,500. This transaction is expected to close on June 5, 2025.
Why It Matters
This capital raise provides Silexion Therapeutics with additional funds, potentially for research and development or operational expansion, which could impact its future growth and product pipeline.
Risk Assessment
Risk Level: medium — The company is raising capital through a share sale, which can dilute existing shareholders and may indicate a need for funding, but the amount is relatively modest.
Key Numbers
- $1.32M — Gross Proceeds (Raised from the sale of ordinary shares.)
- $1.15 — Price Per Share (The price at which ordinary shares were sold.)
- 1,150,000 — Ordinary Shares Sold (The number of shares sold in the transaction.)
Key Players & Entities
- Silexion Therapeutics Corp (company) — Registrant
- June 3, 2025 (date) — Report Date
- May 28, 2025 (date) — Earliest Event Reported
- $1.15 (dollar_amount) — Price per share
- 1,150,000 (dollar_amount) — Number of ordinary shares
- $1,322,500 (dollar_amount) — Gross proceeds
- June 5, 2025 (date) — Expected Closing Date
FAQ
What is the total gross proceeds expected from the securities purchase agreement?
The total gross proceeds expected from the securities purchase agreement are approximately $1,322,500.
What is the price per share for the ordinary shares being sold?
The ordinary shares are being sold at a price of $1.15 per share.
How many ordinary shares are being sold?
1,150,000 ordinary shares are being sold.
When is the expected closing date for this transaction?
The transaction is expected to close on June 5, 2025.
What was the earliest event reported in this filing?
The earliest event reported in this filing was on May 28, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Silexion Therapeutics Corp (SLXNW).